AI Medical Firm 'Zero Hypothesis' Secures Nearly 100 Million Yuan in Series A Funding, with a Focus on Intelligent Academic Exchange
2025-10-31 / Read about 0 minute
Author:小编   

As per a 36Kr report, the AI-powered medical productivity tool provider, 'Zero Hypothesis,' has recently concluded a Series A funding round, raising close to 100 million yuan. The investors in this round include Hetang Venture Capital, Guofang Innovation, and Shanghai Zheyü. Notably, Origin Capital, an existing shareholder, showed strong confidence by oversubscribing, while VCapital played a pivotal role as the exclusive financing advisor. The proceeds from this funding round are earmarked for refining and deploying scenario-specific AI medical intelligent agents, thereby establishing a robust academic communication platform that bridges pharmaceutical companies and medical professionals.